calendar
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,398 8k filing · 2,000 device pma
18,993 catalysts · 18,987 approval · 5,000 device 510k · 4,876 phase readout · 4,728 grant · 2,398 8k filing · 2,000 device pma
Sponsor: LEO PHARMA AS. Form: CREAM. Route: TOPICAL
Sponsor: KRAMER. Form: SHAMPOO. Route: TOPICAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: SPRAY, METERED. Route: NASAL
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: GLAXOSMITHKLINE. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: GENZYME. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
Sponsor: TEVA BRANDED PHARM. Form: TABLET. Route: ORAL
Sponsor: IVAX SUB TEVA PHARMS. Form: TABLET. Route: ORAL
Sponsor: KRAMER. Form: SHAMPOO. Route: TOPICAL
Sponsor: KRAMER. Form: SHAMPOO. Route: TOPICAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: PFIZER. Form: TABLET. Route: ORAL
Sponsor: ADVANZ PHARMA. Form: GEL. Route: TOPICAL
Sponsor: LILLY. Form: INJECTABLE. Route: INJECTION
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: CHEPLAPHARM. Form: TABLET. Route: ORAL
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: HARROW EYE. Form: SUSPENSION/DROPS. Route: OPHTHALMIC
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: CAPSULE. Route: ORAL
Sponsor: NOVARTIS. Form: SUSPENSION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: TERSERA. Form: IMPLANT. Route: IMPLANTATION
Sponsor: NOVITIUM PHARMA. Form: CAPSULE. Route: ORAL
Sponsor: HIKMA. Form: INJECTABLE. Route: INJECTION
Sponsor: HARROW EYE. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: APOTEX. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: KENVUE BRANDS. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: LEO PHARMA AS. Form: CREAM. Route: TOPICAL
Sponsor: LEO PHARMA AS. Form: OINTMENT. Route: TOPICAL